Annual CFO
-$13.72 M
+$2.45 M+15.14%
December 31, 2023
Summary
- As of February 7, 2025, CLPT annual cash flow from operations is -$13.72 million, with the most recent change of +$2.45 million (+15.14%) on December 31, 2023.
- During the last 3 years, CLPT annual CFO has fallen by -$5.91 million (-75.74%).
- CLPT annual CFO is now -381.40% below its all-time high of -$2.85 million, reached on December 31, 2019.
Performance
CLPT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.20 M
+$1.47 M+55.06%
September 30, 2024
Summary
- As of February 7, 2025, CLPT quarterly cash flow from operations is -$1.20 million, with the most recent change of +$1.47 million (+55.06%) on September 30, 2024.
- Over the past year, CLPT quarterly CFO has increased by +$597.00 thousand (+33.24%).
- CLPT quarterly CFO is now -157.13% below its all-time high of -$466.30 thousand, reached on December 31, 2019.
Performance
CLPT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$8.88 M
+$597.00 K+6.30%
September 30, 2024
Summary
- As of February 7, 2025, CLPT TTM cash flow from operations is -$8.88 million, with the most recent change of +$597.00 thousand (+6.30%) on September 30, 2024.
- Over the past year, CLPT TTM CFO has increased by +$6.74 million (+43.16%).
- CLPT TTM CFO is now -371.13% below its all-time high of -$1.88 million, reached on March 31, 2012.
Performance
CLPT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CLPT Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +15.1% | +33.2% | +43.2% |
3 y3 years | -75.7% | +63.6% | +23.1% |
5 y5 years | -196.3% | -24.4% | -211.4% |
CLPT Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -8.1% | +15.1% | -2.6% | +78.9% | at high | +49.8% |
5 y | 5-year | -381.4% | +15.1% | -157.1% | +78.9% | -211.4% | +49.8% |
alltime | all time | -381.4% | +15.1% | -157.1% | +78.9% | -371.1% | +49.8% |
ClearPoint Neuro Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.20 M(-55.1%) | -$8.88 M(-6.3%) |
Jun 2024 | - | -$2.67 M(-30.5%) | -$9.47 M(-20.3%) |
Mar 2024 | - | -$3.84 M(+228.5%) | -$11.88 M(-13.4%) |
Dec 2023 | -$13.72 M(-15.1%) | -$1.17 M(-34.9%) | -$13.72 M(-12.1%) |
Sep 2023 | - | -$1.80 M(-64.6%) | -$15.62 M(-11.6%) |
Jun 2023 | - | -$5.08 M(-10.7%) | -$17.67 M(+0.5%) |
Mar 2023 | - | -$5.68 M(+85.3%) | -$17.58 M(+8.7%) |
Dec 2022 | -$16.17 M(+27.3%) | -$3.06 M(-20.4%) | -$16.17 M(-2.9%) |
Sep 2022 | - | -$3.85 M(-22.7%) | -$16.65 M(+3.5%) |
Jun 2022 | - | -$4.98 M(+16.7%) | -$16.10 M(+8.5%) |
Mar 2022 | - | -$4.27 M(+20.2%) | -$14.84 M(+16.8%) |
Dec 2021 | -$12.70 M(+62.6%) | -$3.55 M(+7.8%) | -$12.70 M(+10.0%) |
Sep 2021 | - | -$3.30 M(-11.4%) | -$11.55 M(+20.1%) |
Jun 2021 | - | -$3.72 M(+74.5%) | -$9.62 M(+26.4%) |
Mar 2021 | - | -$2.13 M(-11.2%) | -$7.61 M(-2.6%) |
Dec 2020 | -$7.81 M(+173.9%) | -$2.40 M(+75.6%) | -$7.81 M(+32.9%) |
Sep 2020 | - | -$1.37 M(-20.0%) | -$5.87 M(+7.4%) |
Jun 2020 | - | -$1.71 M(-26.7%) | -$5.47 M(+19.6%) |
Mar 2020 | - | -$2.33 M(+399.9%) | -$4.57 M(+60.4%) |
Dec 2019 | -$2.85 M(-38.5%) | -$466.30 K(-51.6%) | -$2.85 M(-3.9%) |
Sep 2019 | - | -$964.10 K(+19.0%) | -$2.97 M(-0.4%) |
Jun 2019 | - | -$810.10 K(+32.9%) | -$2.98 M(-9.2%) |
Mar 2019 | - | -$609.50 K(+4.7%) | -$3.28 M(-29.2%) |
Dec 2018 | -$4.63 M | -$582.40 K(-40.3%) | -$4.63 M(-20.1%) |
Sep 2018 | - | -$975.30 K(-12.3%) | -$5.79 M(-10.9%) |
Jun 2018 | - | -$1.11 M(-43.3%) | -$6.50 M(-1.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | -$1.96 M(+12.3%) | -$6.61 M(+10.3%) |
Dec 2017 | -$5.99 M(+3.0%) | -$1.75 M(+3.8%) | -$5.99 M(+11.8%) |
Sep 2017 | - | -$1.68 M(+37.9%) | -$5.36 M(+5.2%) |
Jun 2017 | - | -$1.22 M(-9.4%) | -$5.09 M(-8.4%) |
Mar 2017 | - | -$1.35 M(+21.1%) | -$5.56 M(-4.5%) |
Dec 2016 | -$5.82 M(-32.6%) | -$1.11 M(-21.5%) | -$5.82 M(-3.4%) |
Sep 2016 | - | -$1.42 M(-15.9%) | -$6.03 M(-3.0%) |
Jun 2016 | - | -$1.68 M(+4.7%) | -$6.21 M(-16.6%) |
Mar 2016 | - | -$1.61 M(+22.1%) | -$7.45 M(-13.8%) |
Dec 2015 | -$8.64 M(+19.1%) | -$1.32 M(-17.8%) | -$8.64 M(-7.3%) |
Sep 2015 | - | -$1.60 M(-45.1%) | -$9.31 M(-5.8%) |
Jun 2015 | - | -$2.92 M(+4.2%) | -$9.89 M(+13.8%) |
Mar 2015 | - | -$2.80 M(+40.4%) | -$8.69 M(+19.9%) |
Dec 2014 | -$7.25 M(-6.8%) | -$1.99 M(-8.3%) | -$7.25 M(+7.1%) |
Sep 2014 | - | -$2.18 M(+26.3%) | -$6.77 M(+5.3%) |
Jun 2014 | - | -$1.72 M(+26.7%) | -$6.43 M(-6.7%) |
Mar 2014 | - | -$1.36 M(-10.2%) | -$6.89 M(-11.4%) |
Dec 2013 | -$7.78 M(+4.6%) | -$1.51 M(-17.5%) | -$7.78 M(-8.4%) |
Sep 2013 | - | -$1.84 M(-16.0%) | -$8.49 M(-1.4%) |
Jun 2013 | - | -$2.19 M(-2.5%) | -$8.61 M(+10.5%) |
Mar 2013 | - | -$2.24 M(+0.7%) | -$7.79 M(+4.8%) |
Dec 2012 | -$7.43 M(+19.1%) | -$2.23 M(+13.9%) | -$7.43 M(+42.8%) |
Sep 2012 | - | -$1.95 M(+42.9%) | -$5.21 M(+60.1%) |
Jun 2012 | - | -$1.37 M(-27.4%) | -$3.25 M(+72.6%) |
Mar 2012 | - | -$1.88 M | -$1.88 M |
Dec 2011 | -$6.24 M(-19.0%) | - | - |
Dec 2010 | -$7.71 M | - | - |
FAQ
- What is ClearPoint Neuro annual cash flow from operations?
- What is the all time high annual CFO for ClearPoint Neuro?
- What is ClearPoint Neuro annual CFO year-on-year change?
- What is ClearPoint Neuro quarterly cash flow from operations?
- What is the all time high quarterly CFO for ClearPoint Neuro?
- What is ClearPoint Neuro quarterly CFO year-on-year change?
- What is ClearPoint Neuro TTM cash flow from operations?
- What is the all time high TTM CFO for ClearPoint Neuro?
- What is ClearPoint Neuro TTM CFO year-on-year change?
What is ClearPoint Neuro annual cash flow from operations?
The current annual CFO of CLPT is -$13.72 M
What is the all time high annual CFO for ClearPoint Neuro?
ClearPoint Neuro all-time high annual cash flow from operations is -$2.85 M
What is ClearPoint Neuro annual CFO year-on-year change?
Over the past year, CLPT annual cash flow from operations has changed by +$2.45 M (+15.14%)
What is ClearPoint Neuro quarterly cash flow from operations?
The current quarterly CFO of CLPT is -$1.20 M
What is the all time high quarterly CFO for ClearPoint Neuro?
ClearPoint Neuro all-time high quarterly cash flow from operations is -$466.30 K
What is ClearPoint Neuro quarterly CFO year-on-year change?
Over the past year, CLPT quarterly cash flow from operations has changed by +$597.00 K (+33.24%)
What is ClearPoint Neuro TTM cash flow from operations?
The current TTM CFO of CLPT is -$8.88 M
What is the all time high TTM CFO for ClearPoint Neuro?
ClearPoint Neuro all-time high TTM cash flow from operations is -$1.88 M
What is ClearPoint Neuro TTM CFO year-on-year change?
Over the past year, CLPT TTM cash flow from operations has changed by +$6.74 M (+43.16%)